A thematic review adapted from the author’s 2026 dossier. Medicinal treatments are chosen with a qualified clinical professional and the complete information for the specific product.
01 / Know the plant
A living tradition. A practical understanding.
Cannabis, also known as marijuana, has cultural, spiritual and medicinal meanings, including within traditions connected with reggae and Rastafari. Respect for the plant can sit alongside a precise understanding of its components and uses.
Cannabinoid medicines bring together defined compounds, compositions and clinical goals. Understanding these distinctions helps connect each preparation with the benefits described in the clinical literature.
Tetrahydrocannabinol
A cannabinoid involved in the effects of some medicines used for symptoms such as spasticity, pain and chemotherapy-related nausea.
Cannabidiol
A cannabinoid that does not produce the typical THC high. Purified prescription CBD has an established role in certain epilepsies.2
Hemp as food
Seeds offer protein and unsaturated fats; whole seeds also provide fibre. Their nutritional role complements a varied diet.1
Measured THC and CBD content identifies the composition of a preparation and connects it to the products studied in clinical research.
02 / Documented benefits
Specific medicines. Meaningful benefits.
This thematic review brings together benefits observed for specific medicines in defined clinical settings. Each benefit is described alongside the preparation and condition studied.
| Use | Benefit documented | Clinical context |
|---|---|---|
| Certain epilepsies | Purified prescription CBD reduces seizure frequency in specific syndromes. | Epidyolex is authorised from age two as add-on treatment for Dravet and Lennox–Gastaut with clobazam, and for tuberous sclerosis complex with other epilepsy treatment.2 |
| Multiple sclerosis | Standardised cannabinoid medicines, particularly nabiximols, can improve patient-reported spasticity. | A symptom-focused option for selected adults, assessed with the treating clinical team.3 |
| Chronic pain | Some THC-containing preparations produce small average short-term improvements, especially in neuropathic pain. | The aim is a worthwhile improvement in comfort and daily function for the individual.4 |
| Chemotherapy-related nausea | Oral THC/CBD added to usual antiemetics improved control of persistent nausea and vomiting in a randomised trial. | A supportive-care option to discuss when standard prevention is insufficient.5 |
| Sleep with chronic pain | Reviews report small improvements in sleep, mainly among people with chronic pain. | Better rest can be part of an overall symptom-management plan.6 |
The value of these results is expressed through the outcomes studied: seizure frequency, spasticity, pain, nausea, sleep and everyday function. These outcomes connect clinical research with aspects of daily life that matter to the person.
03 / Hemp & nutrition
Nourishment from the seed.
Hemp seeds are versatile ingredients for plant-based eating. They supply protein and unsaturated fats, while whole seeds also contribute fibre. Add them to porridge, yoghurt, salads or vegetable dishes; hemp seed oil can bring flavour and unsaturated fats to dressings.1
Seeds and seed oil serve a nutritional purpose. Cannabinoid extracts and prescription medicines have different compositions and uses. Keeping those roles clear makes it easier to choose a food for nourishment and a medical preparation for a specific clinical goal.
For an active life, nourishing meals, sleep and a well-paced movement routine work together. Hemp foods can be one useful part of that broader pattern.
Care that makes room for a fuller life.
The most valuable benefit is one you can recognise in daily life: greater comfort, a more manageable symptom or an activity made possible again. Listening to the person keeps that purpose in view.
6 / Reference
Scientific reading
Selected publications on therapeutic benefits and hemp nutrition. Original sources are linked in their publication language. Checked on 19 October 2026.
- Industrial hemp seed: from the field to value-added food ingredients Burton et al. · Journal of Cannabis Research · 2022
- Epidyolex — cannabidiol: clinical and patient product information European Medicines Agency · Current product information · Checked 19 October 2026
- Cannabis and cannabinoids for people with multiple sclerosis Cochrane · Systematic review · 2022
- Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2025 Update Chou et al. · AHRQ · 2025
- Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting: Final Results of a Randomized, Placebo-Controlled, Phase II/III Trial Grimison et al. · Journal of Clinical Oncology · 2024
- Medical cannabis and cannabinoids for impaired sleep: a systematic review and meta-analysis of randomized clinical trials AminiLari et al. · Sleep · 2022